Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT02744612 · COMPLETED
Trial details
- NCT number
- NCT02744612
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-20
- Primary completion
- 2021-03-03
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.